Monitoring sirolimus levels in transplant patients is essential to ensuring the delicate balance between appropriate immunosuppression and transplant rejection. With the EMIT® 2000 sirolimus method, laboratories have a flexible and convenient solution to help clinicians effectively manage sirolimus therapy in their transplant patients.
Features
- Simple sample pretreatment
- Results in as little as 14 minutes
- No reagent preparation required
- Correlates to LC/MS/MS
Advantages
- Streamlined ISD monitoring and enhanced productivity
- Benefit from up to 4 different ISD methods on one single V-Twin® or Viva-E® drug testing system*
Assay Specifications
| Emit 2000 SIRO Assay |
Product Code | 8S019UL |
Sample Type | EDTA Whole Blood |
Pretreatment | Manual |
Reportable Range | 3.5 -30 ng/mL |
Calibration | With new reagent lot |
Reagent Stability | Opened at 2-8° C: 4 weeks |